It is estimated that between 2018 and 2050, the number of people with Alzheimer’s disease in France will increase from 1,227,558 to 2,236,682. Risk factors are increasingly well known. Therapeutic expectations are high and many studies are devoted to them. Early markers, therapeutic perspectives, prevention strategy… The point in this selection of recent articles.
To read:
Mallordy F. Dementia: vision loss and high cholesterol are also modifiable risk factors. Rev Prat (online) September 2, 2024.
Mallordy F. Transcranial magnetic stimulation proves effective against Alzheimer’s disease. Rev Prat 2024;74(6):603.
Martin Agudelo L. Preventing dementia: 5 proven measures. Rev Prat (online) March 15, 2024.
Martin Agudelo L. Is Alzheimer’s disease “transmissible”? Rev Prat (online) February 9, 2024.
Martin Agudelo L. Ultrasound: a hope in Alzheimer’s disease. Rev Prat (online) January 30, 2024.
Sellal F, Weiss C. Memory disease. Rev Prat 2023;73(10);1081 – 4.
Bouvenot G, Le Coz P. New drugs against Alzheimer’s disease: ray of hope or a new mirage? Rev Prat 2023;73(10);1057 – 60.
Mallordy F. The intestinal microbiota involved in Alzheimer’s disease. Rev Prat (online) November 6, 2023.
Nobile C. Interview with Professor Thibaud Lebouvier. Alzheimer’s disease… towards a paradigm shift. Rev Prat (online) February 17, 2023.
Martin Agudelo L. Delaying dementia: sport, sudoku or vitamin D, which is better? Rev Prat (online) September 8, 2023.
Nobile C. Atrial fibrillation and dementia: which anticoagulant should be preferred? Rev Prat (online) May 2, 2023.
Mallordy F. Wearing hearing aids could prevent 20% of avoidable dementias. Rev Prat (online) April 26, 2023.
Martin Agudelo L. Regular use of laxatives promotes dementia. Rev Prat (online) March 14, 2023.
Martin Agudelo L. Ultra-processed foods promote dementia. Rev Prat (online) March 3, 2023.
Nobile C. Six factors to delay cognitive decline. Rev Prat (online) February 7, 2023.
Mallordy F. Early Alzheimer’s: hope for lecanemab? Rev Prat (online) December 20, 2022.
Martin Agudelo L. “One” or “diseases” of Alzheimer’s? Rev Prat (online) November 23, 2021.
Epelbaum S, Dubois B. Item 108. Confusion, dementia (see item 132). Rev Prat 2021;71(1) ;e21 – 8.
Martin Agudelo L. Fine particles: risk factor for Alzheimer’s? Rev Prat (online) December 8, 2020.
Manera V, Robert P. Contribution of serious games in neuropsychiatric disorders. Rev Prat 2020;70(3);247 – 50.
Cognat E, Hourrègue C. Towards blood markers in Alzheimer’s disease. Rev Prat 2020;70(2);156.
Ivanoiu A, Engelborghs S, Hanseeuw B. Early diagnosis of Alzheimer’s disease (with pre-announcement consultation). Rev Prat 2020;70(2);158 – 63.
Frackowiak R. MRI in the diagnosis of Alzheimer’s disease. Rev Prat 2020;70(2);164 – 7.
Farid K. Molecular imaging in the diagnosis of Alzheimer’s disease. Rev Prat 2020;70(2);168 – 9.
Package C. Therapeutic perspectives in Alzheimer’s disease? Rev Prat 2020;70(2);170 – 2.
Hugon J, Paquet C. Transcranial brain stimulation in Alzheimer’s disease. Rev Prat 2020;70(2);173 – 4.
Fayel A, Indart S, Sanchez Ortiz M. Cognitive stimulation in Alzheimer’s disease. Rev Prat 2020;70(2);174 – 6.
Hugon J, Ménard J. Alzheimer’s disease, preclinical and early aspects: 10 key messages. Rev Prat 2020;70(2);177.
Related News :